News

According to researchers at Johns Hopkins Children’s Center, AI-driven cameras take images of the back of the eye and require no eye drops can be used to close care gaps.

Leanne Clevenger, MD, described a case that highlights varying approaches and protocols for addressing a complex case of retinal detachment repair in a patient with trauma to the globe.

David Hutton of Ophthalmology Times talks with Adrienne Scott, MD, FASRS, about her part in a panel discussion detailing emerging therapies for AMD.

David Hutton of Ophthalmology Times talks with Sunir Garg, MD about his surgical video panel at this year's Retina Fellows Forum.

According to the company, favorable safety and tolerability profiles were observed with the first 2 SPVN06 doses across 6 patients. The exploration of SPVN06 in geographic geographic atrophy is set to begin in 2024.

The American subsidiary of the German ophthalmic diagnostic device designer announced in a news release that its OCULUS Easyfield VR™ is now available in the US ophthalmic market

New technology may shift the diagnostic paradigm

A recent study found that despite worldwide reports of ocular inflammatory events being reported after patients received COVID-19 vaccinations, a low amount has been reported in the UK.

A recent study found that despite worldwide reports of ocular inflammatory events being reported after patients received COVID-19 vaccinations, a low amount has been reported in the UK.

Genetic testing is proving to be an evolving technology for ophthalmologists.

According to the company, the research is being conducted in collaboration with London-based Imperial College Healthcare NHS Trust.

The partnership establishes a large-scale enrollment platform for research on MicroPulseTransscleral Laser Therapy (TLT)

Authors believe that PVI and PHMB are not associated with postoperative ocular irritation.

Evaluating injections of anti-VEGF drugs into the intra-anterior chamber may be a viable alternative, but further study is required.

Postoperative outcomes of the tissues obtained from these donors were satisfactory

The new contact lenses contain micro-sensors which monitor changes in IOP over a period of several hours, sending the data collected wirelessly so it can be analyzed by an ophthalmologist and a diagnosis given.

Investigators advised that further studies should be conducted to understand more precisely the benefits and risks

The recall is “due to potential safety concerns after FDA investigators found insanitary conditions.”

Two retina specialists participated in an Ophthalmology Times case-based roundtable discussion and shared their experiences using the anti-VEGF biosimilars, ranibizumab-eqrn and ranibizumab-nuna to manage retinal diseases.

The app is a tool aimed at allowing patients to measure their visual acuity at home by themselves.

According to the companies, the deal also includes Coherus’ CIMERLI biologics license application, ophthalmology sales and select field reimbursement teams. Coherus will now focus on its oncology business.

Evaluating injections of anti-VEGF drugs into the intra-anterior chamber may be a viable alternative, but further study is required.

Clinicians, researchers and stakeholders discussed establishing CVI diagnostic criteria, boosting awareness of CVI and creating a participant data registry

Among 85 trials representing 34 ophthalmic drugs, a study revealed more than of ophthalmology 75% of trials associated with FDA drug approvals conflated sex and gender, while more than two-thirds of these trials lacked any sex- and gender-based data analyses.

A new case-control study found that older people ages 70 and older living in South Korea’s urban areas were at a significantly higher risk for developing incident exudative age-related macular degeneration.

Researchers are unveiling results show previously unknown inherited genetic variants that contribute to primary open-angle glaucoma, the most common form of the disease.